Back to Search
Start Over
Long-term Efficacy and Safety of Recombinant Interferon Alpha-2 vs. Hydroxyurea in Polycythemia Vera: Preliminary Results From the Three-Year Analysis of the DALIAH Trial – A Randomized Controlled Phase III Clinical Trial
- Source :
- Knudsen, T A, Lund Hansen, D, Ocias, L F, Weiss Bjerrum, O, Brabrand, M, El Fassi, D, Frederiksen, M, Kjær, L, Kielsgaard Kristensen, T, Kruse, T A, Mourits-Andersen, H T, Møller, P, Overgaard, U M, Severinsen, M T, Skov, V, Stentoft, J, Starklint, J, de Stricker, K, Thomassen, M, Larsen, T S, Hasselbalch, H C & Hasselbalch, H C 2018, ' Long-term Efficacy and Safety of Recombinant Interferon Alpha-2 vs. Hydroxyurea in Polycythemia Vera: Preliminary Results From the Three-Year Analysis of the DALIAH Trial – A Randomized Controlled Phase III Clinical Trial. ', American Society of Hematology: 60th Annual Meeting (ASH), San Diego, United States, 29/11/2018-04/12/2018 .
- Publication Year :
- 2018
Details
- Language :
- English
- Database :
- OpenAIRE
- Journal :
- Knudsen, T A, Lund Hansen, D, Ocias, L F, Weiss Bjerrum, O, Brabrand, M, El Fassi, D, Frederiksen, M, Kjær, L, Kielsgaard Kristensen, T, Kruse, T A, Mourits-Andersen, H T, Møller, P, Overgaard, U M, Severinsen, M T, Skov, V, Stentoft, J, Starklint, J, de Stricker, K, Thomassen, M, Larsen, T S, Hasselbalch, H C & Hasselbalch, H C 2018, ' Long-term Efficacy and Safety of Recombinant Interferon Alpha-2 vs. Hydroxyurea in Polycythemia Vera: Preliminary Results From the Three-Year Analysis of the DALIAH Trial – A Randomized Controlled Phase III Clinical Trial. ', American Society of Hematology: 60th Annual Meeting (ASH), San Diego, United States, 29/11/2018-04/12/2018 .
- Accession number :
- edsair.od......3062..7f1fd9d3820b15ef349e224893f4d560